The latest closing stock price for Contineum Therapeutics as of March 03, 2025 is 6.59.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-572 today, roughly -1 times their original investment - a -57.21% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 233.8% above the current share price.
The Contineum Therapeutics 52-week low stock price is 6.49, which is 1.5% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 15.83.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-572 today, roughly -1 times their original investment - a -57.21% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 233.8% above the current share price.
The Contineum Therapeutics 52-week low stock price is 6.49, which is 1.5% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 15.83.